Русские видео

Сейчас в тренде

Иностранные видео


Скачать с ютуб Asthma: Causes, Symptoms, Diagnosis & Treatment | Dr. Ashwini Singh | Redcliffe Labs в хорошем качестве

Asthma: Causes, Symptoms, Diagnosis & Treatment | Dr. Ashwini Singh | Redcliffe Labs 3 недели назад


Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса savevideohd.ru



Asthma: Causes, Symptoms, Diagnosis & Treatment | Dr. Ashwini Singh | Redcliffe Labs

More than 80 percent of asthma cases in India are undiagnosed, and if left untreated, they can worsen over time. Watch the video featuring Dr. Ashwini Singh, MBBS, MD in Public Health and Family Medicine to learn more about Asthma, its symptoms, its influence on the body, management strategies, and more that can make the condition manageable. She answered the most common questions people have about Asthma. So, dive in to empower yourself with the right knowledge. #BreatheEasyYaar #bestpathologylabs #bestdiagnosticcentre --------------------------------------------------------------------------------------------------------- Book your test : 🌐 https://redcliffelabs.com/ 📞 9289589001, 898 898 8787 Read the Blogs- https://bit.ly/3PeutHT ------------------------------------------------------------------------------------- About Redcliffe Labs: We help doctors and patients to plan an accurate and appropriate treatment by helping them with the right diagnosis for a particular medical condition. We are available around the clock to provide our patients with highly competent, evidence-based and state-of-the-art diagnostic expertise. For more updates follow us on:- Facebook:-   / redcliffelabs   Instagram:-   / redcliffelabs   LinkedIn:-   / redcliffe-labs   Twitter:-   / redcliffelab   Website:- https://redcliffelabs.com/ Book your appointment at +91-8988988787, for any queries mail us at [email protected] --------------------------------------------------------------------------------------------

Comments